Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer
Clinical trial NCT07436858 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07436858
- Sponsor
- The Netherlands Cancer Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-07
- Primary completion
- 2030-07-07
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.